Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Bender Jeremy. Director active across 3 companies, notably Day One Biopharmaceuticals, Inc.. Aggregated, 39 filings have been recorded. Split: 0 buy · 13 sells. Total volume traded: €3.5m. History available since 1 July 2022. The latest transaction was disclosed on 7 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bender Jeremy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12,500 shares@ US$20.00916.7% of flowCommon StockSEC:0001209191-23-017295:0
25 of 39 declarations
About Bender Jeremy
Bender Jeremy is a declarant who has made 28 filings in total. In his most recent filings, he sold shares of Day One Biopharmaceuticals, Inc. for a total amount of 3,503,978 euros, with the first transaction recorded on July 6, 2022, and the last on May 19, 2025. Notable transactions include a sale of 1,167,910.79 euros on May 3, 2024, and several other sales in 2022 and 2023.